EUVIMEDEUVIMED entdecken
Crossref

Macrophage‐Targeted Efferocytosis Therapy Promotes Diabetic Wound Healing via Cellular Level Debridement

Yi Chen, Wei Chen, Yiming Ren, Yanjie Zhang, Zhaoqi Tan, Wenzhe Huang, Xueshan Bai, Liya Yang, Shuyun Liu, Quanyi Guo, Li Teng

Advanced Functional Materials · 2025-11 · 35 (46)

DOI: 10.1002/adfm.202503035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Functional Materials, online erschienen am 27.05.2025. Verfasst von Yi Chen und 10 weiteren Autor:innen. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Impaired efferocytosis in diabetic wounds contributes to apoptotic cell accumulation, chronic inflammation, and poor healing outcomes. In this study, a multi‐hierarchical hydrogel designed to facilitate cellular debridement and initiate a healing process in diabetic wounds is proposed. A reactive oxygen species (ROS)/glucose‐responsive hydrogel conjugated with chemokine aptamers is developed that encapsulated mannose‐modified lipid nanoparticles (mLNPs) loaded with ADAM17 siRNA (A disintegrin and metalloproteinase 17). This hydrogel enhanced macrophage recruitment by enriching endogenous chemokines. Additionally, it responded to the pathological microenvironment, enabling the dynamic release of mLNPs for targeted siRNA delivery to macrophages. Treatment with ADAM17 siR@mLNPs significantly enhanced macrophage efferocytosis through the MerTK‐Rac1 pathway and glycolytic reprogramming, thereby initiating the resolution of inflammation and tissue repair. Finally, in animal models of diabetic wounds, this therapy reduced the apoptotic burden and improved wound healing. In conclusion, macrophage‐targeted efferocytosis‐reactivation therapy is a promising strategy for the treatment of diabetic wounds.

Förderung

  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Chen, Y., Chen, W., Ren, Y., Zhang, Y., Tan, Z., Huang, W., Bai, X., Yang, L., Liu, S., Guo, Q., & Teng, L. (2025). Macrophage‐Targeted Efferocytosis Therapy Promotes Diabetic Wound Healing via Cellular Level Debridement. Advanced Functional Materials, 35(46). https://doi.org/10.1002/adfm.202503035

Vancouver

Chen Y, Chen W, Ren Y, Zhang Y, Tan Z, Huang W, et al. Macrophage‐Targeted Efferocytosis Therapy Promotes Diabetic Wound Healing via Cellular Level Debridement. Advanced Functional Materials. 2025;35(46). doi:10.1002/adfm.202503035

BibTeX
@article{Chen2025,
  author = {Chen, Yi and Chen, Wei and Ren, Yiming and Zhang, Yanjie and Tan, Zhaoqi and Huang, Wenzhe and Bai, Xueshan and Yang, Liya and Liu, Shuyun and Guo, Quanyi and Teng, Li},
  title = {Macrophage‐Targeted Efferocytosis Therapy Promotes Diabetic Wound Healing via Cellular Level Debridement},
  journal = {Advanced Functional Materials},
  year = {2025},
  volume = {35},
  number = {46},
  doi = {10.1002/adfm.202503035}
}
Kostenlos starten →